Reduction of PTSD Symptoms With Pre-Reactivation Propranolol Therapy: A Randomized Controlled Trial

Overview of attention for article published in American Journal of Psychiatry, January 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 7 news outlets
blogs: 1 blog
policy: 2 policy sources
twitter: 29 X users
patent: 2 patents

facebook: 2 Facebook pages
reddit: 6 Redditors
video: 1 YouTube creator
podcasts: 1 podcast

Readers on

mendeley: 327 Mendeley

So far, Altmetric has seen 2 policy documents that reference this research output.

Propranolol for Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness - Propranolol for Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 18 Mar 2020

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Translating Molecular and Neuroendocrine Findings in PTSD and Resilience to Novel Therapies

Cited by Centers for Disease Control and Prevention (CDC) on 12 Dec 2019

CDC is America’s leading public health agency, dedicated to saving and protecting the health of Americans. CDC monitors health, informs decisionmakers, and provides people with information so they can take responsibility for their own health.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.